Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19875946 | 0.90 | MEN1 (0.37) | MAPK1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL27624397 | 0.81 | TSHR (0.33) | TSHR | |
| SCHEMBL1167334 | 0.81 | — | — | |
| SCHEMBL18705909 | 0.80 | RAB9A (0.36) | MEN1KMT2ATDP1SMN1; SMN2CA1 | |
| SCHEMBL8640855 | 0.79 | ALDH1A1 (0.43) | MAPK1TSHRMEN1KMT2ATDP1 | |
| SCHEMBL8752385 | 0.79 | TSHR (0.48) | TSHRTDP1ALDH1A1SMN1; SMN2CA1 | |
| SCHEMBL1419465 | 0.77 | LTA4H (0.41) | MAPK1TDP1SMN1; SMN2CA2 | |
| SCHEMBL1180141 | 0.77 | TDP1 (0.58) | MAPK1TSHRMEN1KMT2ATDP1 | |
| Di(Hydroxyethyl)Ether SCHEMBL16085977 | 0.77 | TDP1 (0.58) | MAPK1TSHRMEN1KMT2ATDP1 | |
| SCHEMBL1167599 | 0.76 | ENPP2 (0.35) | TSHRLMNACA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 557 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3436428-B1 | BISPHENOL M DIPHTHALONITRILE ETHER RESIN, BISPHENOL P DIPHTHALONITRILE ETHER RESIN, METHODS OF MAKING SAME, RESIN BLENDS, AND TWO COMPONENT SYSTEMS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-07-10 | — | — | EP | disclosed |
| CN-118265569-A | Method for purification of biological material | 舒万诺知识产权公司 | 2024-06-28 | — | — | CN | disclosed |
| US-20240199920-A1 | ARTICLES CONTAINING ADHESIVE COMPOSITIONS EXHIBITING ON-DEMAND DEBONDING BEHAVIOR | 3M INNOVATIVE PROPERTIES COMPANY | 2024-06-20 | — | — | US | disclosed |
| EP-4136070-B1 | MONOMERS, POLYMERS, AND ARTICLES FOR BIOMATERIAL CAPTURE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-05-29 | — | — | EP | disclosed |
| CN-115443266-B | Monomers, polymers and articles for biomaterial capture | 舒万诺知识产权公司 | 2024-05-17 | — | — | CN | disclosed |
| EP-4347246-A1 | ARTICLES CONTAINING ADHESIVE COMPOSITIONS EXHIBITING ON-DEMAND DEBONDING BEHAVIOR | 3M Innovative Properties Company (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4107217-B1 | POLYMERIZABLE COMPOSITIONS INCLUDING A PHTHALONITRILE RESIN AND A POLYOXOMETALATE, ARTICLES, AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-03-27 | — | — | EP | disclosed |
| US-11932750-B2 | Resin blends including phthalonitrile resin and thiadiazole substituted phthalonitrile compound, articles, compounds, and methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-03-19 | — | — | US | disclosed |
| CN-117412856-A | Articles containing adhesive compositions exhibiting on-demand debonding behavior | 3M创新有限公司 | 2024-01-16 | — | — | CN | disclosed |
| EP-3864002-B1 | ADDITION-FRAGMENTATION AGENT WITH PENDENT AMINE GROUPS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-12-27 | — | — | EP | disclosed |
| US-20100307680-A1 | BENZOXAZINE-THIOL ADDUCTS | 3M INNOVATIVE PROPERTIES COMPANY | 2010-12-09 | — | — | US | disclosed |
| US-20100311861-A1 | THIOL-YNE SHAPE MEMORY POLYMER | 3M INNOVATIVE PROPERTIES COMPANY | 2010-12-09 | — | — | US | disclosed |
| US-20100312004-A1 | BENZOXAZINE-THIOL ADDUCTS | 3M INNOVATIVE PROPERTIES COMPANY | 2010-12-09 | — | — | US | disclosed |
| WO-2010141274-A1 | THIOL-YNE SHAPE MEMORY POLYMER | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-12-09 | — | — | WO | disclosed |
| US-7442760-B2 | Electroactive polymers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-10-28 | — | — | US | disclosed |
| US-7094902-B2 | Electroactive polymers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-08-22 | — | — | US | disclosed |
| US-20060155106-A1 | ELECTROACTIVE POLYMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2006-07-13 | — | — | US | disclosed |
| EP-1573789-A2 | ELECTROACTIVE POLYMERS | 3M Innovative Properties Company (US) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004102615-A2 | ELECTROACTIVE POLYMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2004-11-25 | — | — | WO | disclosed |
| US-20040062930-A1 | Electroactive polymers | 3M INNOVATIVE PROPERTIES COMPANY | 2004-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100312004-A1 | BENZOXAZINE-THIOL ADDUCTS | AOX1, GJA1, PRDX4 | MAPK1 4754/4885TSHR 4761/4885MEN1 4858/4885 |
| US-11932750-B2 | Resin blends including phthalonitrile resin and thiadiazole substituted phthalonitrile compound, articles, compounds, and methods | THUMPD1, RBBP5, RB1 | MAPK1 3793/4885TSHR 3738/4885MEN1 2787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.